Nancy Cox, a globally recognized leader in influenza research and a longtime figure at the U.S. Centers for Disease Control and Prevention (CDC), has died. She was 77.
Cox passed away on Thursday after a battle with glioblastoma, an aggressive form of brain cancer.
Decades of Leadership in Flu Research
For 22 years, Cox led the CDC’s influenza team, transforming it from a small branch of 14 employees into a major division of more than 100 scientists and researchers. Her leadership helped shape global influenza surveillance, prevention, and response strategies.
In addition to her work at the CDC, Cox served as the director of the World Health Organization’s (WHO) Collaborating Center for the Surveillance, Epidemiology, and Control of Influenza, based at the CDC. This center plays a critical role in coordinating international efforts to monitor and combat influenza outbreaks worldwide.
Legacy in Public Health
Cox’s contributions extended beyond the United States. She was a key figure in global health initiatives, including the WHO’s Global Influenza Surveillance and Response System (GISRS). Her work helped strengthen pandemic preparedness and response, particularly during outbreaks such as the 2009 H1N1 pandemic.
Colleagues and public health experts have mourned her loss, praising her dedication, expertise, and mentorship.
"Nancy was a true pioneer in influenza research and a mentor to generations of scientists," said a spokesperson for the CDC. "Her leadership and vision have left an indelible mark on global health."
Tributes and Remembrance
Tributes have poured in from the scientific community, highlighting Cox’s impact on virology and epidemiology. Many have noted her ability to bridge research and public health policy, ensuring that scientific advancements translated into real-world protections for communities.
The CDC and WHO are expected to honor Cox’s legacy with future initiatives aimed at continuing her work in influenza prevention and control.
Related articles
Robert F. Kennedy Jr. Balances Vaccine Skepticism with Ohio Outreach Tour
Here in Washington, we’ve been hearing about tensions between the White House and one of its most controversial — but, at least in some circles, most...
Global Health Alert: Ebola and Hantavirus Outbreaks Highlight Gaps in Pandemic Preparedness
The reports emerging this week of a major Ebola outbreak in the Democratic Republic of Congo, coming alongside a growing hantavirus outbreak linked to...
Why Alcohol Remains Overlooked Despite Its Deadly Toll in the U.S.
Alcohol kills more Americans than any other drug by a wide margin. But discussions about substance use epidemics in the U.S. are usually centered arou...
PSA Screening Significantly Lowers Prostate Cancer Death Risk, Cochrane Review Confirms
Prostate-specific antigen (PSA) blood testing is likely to reduce the risk of death from prostate cancer, found a new review published on Thursday by...
STAT Unveils 'The Deadliest Drug' Investigation: Alcohol-Related Deaths Surpass 178,000 Annually in the U.S.
Dear Readers, I want to bring your attention to “The Deadliest Drug,” a new STAT investigative series about our nation’s failure to address excessive...
CDC to Relocate 160+ Monkeys to Sanctuary in Bid to End Animal Testing
As part of efforts to phase out the use of monkeys in research, the Centers for Disease Control and Prevention intends to transfer more than 160 macaq...
Who Will Lead the FDA Next? The Search for a New Commissioner Heats Up
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to...
MIT Research Funding Drops 10% Amid Federal Cuts and Immigration Policy Changes
MIT President Sally Kornbluth said Thursday that the school’s research enterprise has shrunk 10 percent from a year ago and warned of a persistent dro...